Breaking News
December 16, 2018 - A biomarker in the brain’s circulation system may be Alzheimer’s earliest warning
December 16, 2018 - Magnesium may play important role in optimizing vitamin D levels, study shows
December 16, 2018 - The effect of probiotics on intestinal flora of premature babies
December 16, 2018 - Parents spend more time talking with kids about mechanics of using mobile devices
December 16, 2018 - Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
December 16, 2018 - Arterial stiffness may predict dementia risk
December 16, 2018 - Study explores link between work stress and increased cancer risk
December 16, 2018 - Sex work criminalization linked to incidences of violence finds study
December 16, 2018 - Johns Hopkins researchers discover swarming behavior in fish-dwelling parasite
December 16, 2018 - Schistosomiasis prevention and treatment could help control HIV
December 16, 2018 - Early postpartum opioids linked with persistent usage
December 16, 2018 - Johns Hopkins researchers identify molecular causes of necrotizing enterocolitis in preemies
December 16, 2018 - Advanced illumination expands capabilities of light-sheet microscopy
December 16, 2018 - Alzheimer’s could possibly be spread via contaminated neurosurgery
December 16, 2018 - Unraveling the complexity of cancer biology can prompt new avenues for drug development
December 16, 2018 - Inflammatory Bowel Disease, Prostate Cancer Linked
December 16, 2018 - Cannabis youth prevention strategy should target mental wellbeing
December 15, 2018 - Recent developments and challenges in hMAT inhibitors
December 15, 2018 - Sewage bacteria found lurking in Hudson River sediments
December 15, 2018 - CDC selects UMass Amherst biostatistician model that helps predict influenza outbreaks
December 15, 2018 - Researchers reveal brain mechanism that drives itch-evoked scratching behavior
December 15, 2018 - New computer model helps predict course of the disease in prostate cancer patients
December 15, 2018 - Obesity to Blame for Almost 1 in 25 Cancers Worldwide
December 15, 2018 - How the brain tells you to scratch that itch
December 15, 2018 - New findings could help develop new immunotherapies against cancer
December 15, 2018 - World’s largest AI-powered medical research network launched by OWKIN
December 15, 2018 - Young people suffering chronic pain battle isolation and stigma as they struggle to forge their identities
December 15, 2018 - Lifespan extension at low temperatures depends on individual’s genes, study shows
December 15, 2018 - New ingestible capsule can be controlled using Bluetooth wireless technology
December 15, 2018 - Researchers uncover microRNAs involved in the control of social behavior
December 15, 2018 - Research offers hope for patients with serious bone marrow cancer
December 15, 2018 - Link between poverty and obesity is only about 30 years old, study shows
December 15, 2018 - Mass spectrometry throws light on old case of intentional heavy metal poisoning
December 15, 2018 - BeyondSpring Announces Phase 3 Study 105 of its Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis
December 15, 2018 - Study finds that in treating obesity, one size does not fit all
December 15, 2018 - Tenacity and flexibility help maintain psychological well-being, mobility in older people
December 15, 2018 - Study reveals role of brain mechanism in memory recall
December 15, 2018 - High levels of oxygen encourage the brain to remain in deep, restorative sleep
December 15, 2018 - Experimental HIV vaccine strategy works in non-human primates, research shows
December 15, 2018 - Genetically modified pigs could limit replication of classical swine fever virus, study shows
December 15, 2018 - FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
December 15, 2018 - Cost and weight-loss potential matter most to bariatric surgery patients
December 15, 2018 - Cancer Research UK and AstraZeneca open new Functional Genomics Centre
December 15, 2018 - New research lays out potential path for treatment of Huntington’s disease
December 15, 2018 - Prestigious R&D 100 Award presented to Leica Microsystems
December 15, 2018 - Study shows septin proteins detect and kill gut pathogen, Shigella
December 15, 2018 - Study sheds new light on disease-spreading mosquitoes
December 15, 2018 - 2017 Saw Slowing in National Health Care Spending
December 15, 2018 - Monitoring movement reflects efficacy of mandibular splint
December 15, 2018 - Study supports BMI as useful tool for assessing obesity and health
December 15, 2018 - Self-guided, internet-based therapy platforms effectively reduce depression
December 15, 2018 - Organically farmed food has bigger climate impact than conventional food production
December 15, 2018 - Faster, cheaper test has potential to enhance prostate cancer evaluation
December 15, 2018 - Researchers study abnormal blood glucose levels of patients after hospital discharge
December 15, 2018 - Swedish scientists explore direct association of dementia and ischemic stroke deaths
December 15, 2018 - Study finds 117% increase in number of dementia sufferers in 26 years
December 15, 2018 - Eczema Can Drive People to Thoughts of Suicide: Study
December 15, 2018 - Link between neonatal vitamin D deficiency and schizophrenia confirmed
December 15, 2018 - Nurse denied life insurance because she carries naloxone
December 15, 2018 - Ritalin drug affects organization of pathways that build brain networks used in attention, learning
December 15, 2018 - Research pinpoints two proteins involved in creation of stem cells
December 15, 2018 - Gut bacteria may modify effectiveness of anti-diabetes drugs
December 15, 2018 - A new type of ‘painless’ adhesive for biomedical applications
December 15, 2018 - Early physical therapy associated with reduction in opioid use
December 15, 2018 - Breast cancer protection from pregnancy begins many decades later, study finds
December 15, 2018 - How often pregnant women follow food avoidance strategy to prevent allergy in offspring?
December 15, 2018 - Using machine learning to predict risk of developing life-threatening infections
December 15, 2018 - How imaginary friends could boost children’s development
December 15, 2018 - Folate deficiency creates more damaging chromosomal abnormalities than previously known
December 15, 2018 - Study provides new insights into molecular mechanisms underlying role of amyloid in Alzheimer’s disease
December 15, 2018 - For the asking, a check is in the mail to help pay for costly drugs
December 15, 2018 - UA scientists uncover biological processes leading to rare brain disorder in babies
December 15, 2018 - The largest database on industrial poisons
December 15, 2018 - ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients
December 15, 2018 - Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome
December 15, 2018 - Left ventricular noncompaction – Genetics Home Reference
December 15, 2018 - Children’s sleep not significantly affected by screen time, new study finds
December 15, 2018 - When should dementia patients stop driving? A new guidance for clinicians
December 15, 2018 - Researchers use INTEGRA’s VIAFLO 96/384 to streamline the experimental workflow
December 15, 2018 - Researchers discover protein involved in nematode stress response
New federally-funded research project could lead to treatments that extend human lifespan

New federally-funded research project could lead to treatments that extend human lifespan

image_pdfDownload PDFimage_print

A new federally-funded research project at the Ohio University Edison Biotechnology Institute and Heritage College of Osteopathic Medicine could lead to treatments that extend human lifespan and allow people to enjoy better health in their old age. The study, led by John Kopchick, Ph.D., has been awarded a five-year grant for more than $2.23 million from the National Institutes of Health.

“We’re very excited about it,” said Kopchick, Goll-Ohio Eminent Scholar and Distinguished Professor of Molecular Biology in the Department of Biomedical Sciences at the Heritage College, and principal investigator at the Edison Biotechnology Institute at Ohio University. He noted that one of the main objectives of NIH’s National Institute on Aging is funding research to increase human “healthspan,” which translates as “a better old age; a healthier old age.”

Among those collaborating with Kopchick on the new research will be co-investigators Darlene Berryman, Ph.D., R.D., L.D., associate dean for research and innovation at the Heritage College, and Edward List, Ph.D., associate investigator with the Edison Biotechnology Institute.

“Dr. Kopchick’s research on growth hormone has been tremendously important for our college, the University and the whole field of endocrinology,” said Ken Johnson, D.O., executive dean of the Heritage College and OHIO’s chief medical affairs officer. “This new avenue of that research, in collaboration with Dr. Berryman and Dr. List, has the potential to make real improvements in the health and wellness of our aging population. It’s very exciting that it’s happening here.”

Kopchick, who is principal investigator on the new project, said it builds on his past research in growth hormone, which led to the discovery of the GH receptor antagonist drug, pegvisomant (trade name Somavert®). This drug, the first specific drug of its kind, is used to treat the disease acromegaly, and its commercialization has yielded $97 million in royalty income to Ohio University as of 2018.

“Dr. Kopchick is a world-renowned researcher whose work has been life-changing for those who suffer from acromegaly,” Ohio University President Dr. M. Duane Nellis said. “With this grant, Dr. Kopchick and his team will remain on the cutting edge of growth hormone research and its impact on aging. We’re proud that such revolutionary work is happening here at OHIO.”

Unlocking the secrets of the world’s oldest mouse

In the early 1990s, Kopchick and a graduate assistant genetically engineered a strain of mouse in which the receptor gene for GH was disrupted, preventing it from working. The dwarf mouse that resulted was found to live longer than normal mice (it holds the world record for oldest lab mouse) and to be healthier in significant ways. These mice are resistant to cancer, diabetes and cognitive decline and show less accumulation of senescent cells (cells that have stopped dividing and that play a role in aging). Kopchick’s team has supplied these long-lived mice to gerontology researchers all over the world.

The long-term goal of the new project, according to a description given to NIH, is “to determine the molecular mechanisms that are responsible for these remarkable health and longevity benefits.”

The researchers will investigate whether the health and lifespan improvements seen in the mice that were genetically modified in utero can be replicated if the disruption of the GH receptor gene is initiated in adult mice at six months of age – corresponding to about 25 years old for a human. They also want to see if lifespan can be further extended by treating the animals with rapamycin, a drug known to lengthen the lives of mice.

“There are two aims in the grant,” Kopchick explained. “One is disrupting the gene in the early adult life of a mouse. The second is to take the long-lived mouse, the longest-lived mouse in the world, and see if we can make it live longer and healthier by adding rapamycin, which in normal mice will promote longevity a bit. So we want to tweak what we already did to see if we can make it better.”

A promising approach to life extension

Kopchick noted that at a workshop of scientific experts on aging, held in Italy in 2013, participants discussed the various types of interventions now available for extending human lifespan. An article on the workshop in the journal Aging Cell, titled “Interventions to slow aging in humans: Are we ready?” recounted that the participants voted on six known life-extending strategies, ranking Kopchick’s drug, the GH receptor antagonist, as the most promising.

“That’s really what led to us doing all this work,” Kopchick said. “The idea is, could a drug – our drug or similar compound – be used, not to delete the growth hormone receptor in humans, but to tie it up, to antagonize it, to prevent it from working.” If the two aims of the research are successful, he believes this would suggest the approach should be tried with humans. He added that his team has already disrupted the GH receptor gene in mice of about six weeks old and found that in mice so treated, females do live longer.

“So we have the longest-lived mouse, and we know that in young life we can see the [increased longevity] effect in females,” he said. “Now we want to see if we can see it in later adult life, and if we can, then can we use our drug or some similar yet-to-be-discovered compound to slow aging?”

Tagged with:

About author

Related Articles